News in Brief
Concept Life Sciences doubles capacity at analytical services facility
The drug discovery, development, and analytical services company has invested £250,000 ($338,000) in new equipment at its East Kilbride analytical services site.
According to the company, the investment doubles capacity across several capabilities, including GC/MS (Gas Chromatography/Mass Spectrometry), GC/MS headspace (for analysis of volatile compounds), GCxGC (comprehensive two-dimensional gas chromatography), and metal and anion analysis.
The company also expects to increase its headcount at the site by eight, in order to support the increase in capacity and workload.
Concept Life Sciences also invested £250,000 ($338,000) in new instrumentation added to the East Kilbride facility last year.